September 30, 2009 and December
31, 2008, respectively 1,531 1,522
Paid-in capital 12,750,025 13,011,012
Statutory reserves 3,178,861 3,178,861
Retained earnings 26,084,749 22,146,572
Accumulated other comprehensive
income 4,432,020 4,428,294
Total shareholders' equity 46,447,186 42,766,261
NONCONTROLLING INTERESTS 592,396 835,532
Total equity 47,039,582 43,601,793
Total liabilities and equity $53,044,395 $44,681,316
CHINA MEDICINE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine months ended September 30,
2009 2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income attributable to China
Medicine Corporation $3,812,184 $5,607,177
Net loss attributable to
noncontrolling interests (242,953) (85,087)
Net income 3,569,231 5,522,090
Adjustments to reconcile net income
to cash provided by (used in)
operating activities:
Depreciation and amortization 663,645 289,935
Loss on sale of assets 27,102 --
Stock option and warrant
compensation 101,336 83,467
Amortization of deferred expenses -- 265,971
Change in fair value of warrant
liabilities 2,113,589
'/>"/>SOURCE China Medicine Corporation Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Related medicine technology :1.
Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference2.
China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems3.
China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou4.
NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company5.
China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS6.
China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance7.
Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X-Ray Image Detectors and X-Ray Tubes at the CMEF Show in Chengdu, China8.
China Medical Technologies to Hold its Annual General Meeting on November 16, 20099.
Reportlinker Adds Outsourcing Preclinical Studies to China10.
Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China11.
China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results